Abstract
We report a case of leiomyosarcoma of mesenthelium origin, which was successfully treated with a combination of cyclophosphamide, vincristine, adriamycin and dacarbazine (CYVADIC). A 56-year-old woman received three courses of adjuvant CYVADIC chemotherapy after initial surgery consisting of tumorectomy, sigmoidectomy, descending colostomy, cystectomy and ureterostomy. A six-month disease-free period was attained obtained. A recurrent tumor showed remarkable reduction after three courses of CYVADIC chemotherapy. This case may be the first report of successful chemotherapy against a leiomyosarcoma of mesenthelium origin in Japan.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Chemotherapy, Adjuvant
-
Colon, Sigmoid / surgery
-
Colostomy
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Dacarbazine / administration & dosage
-
Doxorubicin / administration & dosage
-
Drug Administration Schedule
-
Female
-
Humans
-
Leiomyosarcoma / drug therapy*
-
Leiomyosarcoma / surgery
-
Middle Aged
-
Sigmoid Neoplasms / drug therapy*
-
Sigmoid Neoplasms / surgery
-
Urinary Bladder / surgery
-
Vincristine / administration & dosage
Substances
-
Vincristine
-
Dacarbazine
-
Doxorubicin
-
Cyclophosphamide